Supplier
Nashat Y Gabrail MD INC
Nashat Y Gabrail MD INC was paid $160K by Medicaid between Jan 2018 and Nov 2024, across 26 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 28% of everything it billed.
33Billing provider infoNASHAT Y GABRAIL MD INC
CANTON, OH 44718
CANTON, OH 44718
33aNPI1346219466assigned 03/14/2006
33bProvider typeDurable Medical Equipment & Medical Supplies
28Total paid$160K
24GClaims23,315
24DCodes billed26
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Durable Medical Equipment & Medical Supplies providers in Ohio
Rank by total paid#177 of 420
Median peer was paid$62K
This provider vs. median2.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,714 | $64K | |
| 2019 | 3,162 | $20K | |
| 2020 | 1,849 | $14K | |
| 2021 | 3,064 | $33K | |
| 2022 | 2,196 | $9K | |
| 2023 | 3,944 | $15K | |
| 2024incomplete | 1,386 | $4K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 28% | 1,065 | 781 | $45K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 14% | 626 | 319 | $22K |
| 96367 | 10% | 843 | 440 | $16K | |
| 80053 | Comprehensive metabolic panel | 7.2% | 2,177 | 1,256 | $12K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.6% | 2,733 | 1,524 | $11K |
| 82575 | 6.4% | 2,167 | 1,253 | $10K | |
| 83735 | 4.2% | 2,142 | 1,231 | $7K | |
| 83615 | 4.1% | 2,169 | 1,249 | $7K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3.4% | 364 | 317 | $5K |
| 84100 | 3.3% | 2,167 | 1,247 | $5K | |
| 84550 | 3.2% | 2,165 | 1,242 | $5K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.6% | 104 | 82 | $3K |
14 more codes
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 1.5% | 559 | $2K |
| 96368 | 1.4% | 330 | $2K | |
| 36415 | Collection of venous blood by venipuncture | 1.3% | 1,676 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.0% | 87 | $2K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 73 | $2K |
| 96415 | <1% | 70 | $1K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 37 | $798.51 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,341 | $492.78 |
| 96523 | <1% | 226 | $302.55 | |
| 82728 | <1% | 16 | $185.19 | |
| 83550 | <1% | 16 | $118.67 | |
| 83540 | <1% | 16 | $87.90 | |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | <1% | 110 | $50.37 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 36 | $29.34 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGABRAIL, NASHAT (PRES/OWNER)